SCHEDULE: Goldman Sachs Discloses 6.3% Stake in TNL MEDIAGENE
Beneficial Ownership Disclosure
Goldman Sachs Group and its subsidiary have disclosed a 6.3% beneficial ownership stake in TNL MEDIAGENE, holding 171,113 ordinary shares.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, have filed a Schedule 13G, disclosing beneficial ownership of 171,113 ordinary shares of TNL MEDIAGENE.
- This ownership represents 6.3% of the class of Ordinary Shares, par value $0.0001 per share, of TNL MEDIAGENE.
- The shares are held with shared voting power and shared dispositive power by both reporting persons.
- The acquisition of these securities was made in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- The filing date for this statement is January 6, 2026, reflecting ownership as of December 31, 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive disclosure. While a Schedule 13G is a routine compliance filing, the presence of a significant stake by Goldman Sachs can be interpreted as a positive signal of institutional confidence in TNL MEDIAGENE.
Positives
- A significant institutional investor like Goldman Sachs holding a 6.3% stake can be viewed as a vote of confidence in TNL MEDIAGENE.
- The disclosure indicates the shares were acquired in the ordinary course of business, suggesting a standard investment rather than an activist position.
Negatives
- The filing itself does not contain any negative financial or operational information about TNL MEDIAGENE, as it is a disclosure of ownership.
Risks
- The filing does not explicitly mention risks related to TNL MEDIAGENE's operations or financial health, as it is a disclosure of beneficial ownership.
Future Outlook
The filing does not provide any forward-looking statements or guidance regarding TNL MEDIAGENE's future performance or strategic direction.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
StockSavvy.ai notes that a Schedule 13G filing by a major financial institution like Goldman Sachs indicates a passive investment exceeding 5% of a company's outstanding shares. While not an endorsement of future performance, it signals institutional interest in TNL MEDIAGENE, potentially increasing its visibility among other institutional investors and the broader market.
Comparison to Industry Standards
- This filing is a standard disclosure required when an entity acquires more than 5% of a company's voting shares, consistent with SEC regulations for passive investors.
- The beneficial ownership percentage of 6.3% is a notable stake, placing Goldman Sachs among the significant shareholders of TNL MEDIAGENE, similar to other institutional holdings seen in comparable media or technology companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact | Papa Lette, Akash Keshari, Regina Chan, Andrzej Szyszka, Ameen Soetan, Rahail Patel, Santosh Vinayagamoorthy, Sadhiya Raffique, Matthew Pomfret, Abhishek Vishwanathan, Mariana Audeves, Veronica Mupazviriwo, Elizabeth Novak, Sam Prashanth (for The Goldman Sachs Group, Inc.) | Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, Matthew Pomfret (for The Goldman Sachs Group, Inc.) | 2025-07-16 | Superseded previous Power of Attorney dated July 29, 2024, expanding or updating the list of authorized attorneys-in-fact. |
| Attorney-in-fact | Papa Lette, Akash Keshari, Regina Chan, Andrzej Szyszka, Ameen Soetan, Rahail Patel, Santosh Vinayagamoorthy, Sadhiya Raffique, Matthew Pomfret, Abhishek Vishwanathan, Mariana Audeves Martinez, Veronica Mupazviriwo, Elizabeth Novak, Sam Prashanth (for Goldman Sachs & Co. LLC) | Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, Matthew Pomfret (for Goldman Sachs & Co. LLC) | 2025-07-16 | Superseded previous Power of Attorney dated October 1, 2024, expanding or updating the list of authorized attorneys-in-fact. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC updated their Powers of Attorney, appointing a new and expanded list of individuals as attorneys-in-fact for SEC filings. These new powers of attorney supersede previous versions. | 2025-07-16 | This update streamlines the process for authorized individuals to execute SEC filings on behalf of Goldman Sachs, ensuring compliance and operational efficiency in reporting beneficial ownership and other regulatory disclosures. |
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holder like Goldman Sachs may increase investor confidence and potentially attract further institutional interest, which could positively influence share price.
- Management: Awareness of a major institutional investor on the shareholder register may influence management's strategic decisions and communication with the investment community.
Key Dates
| Date | Description |
|---|---|
| 2024-07-29 | Previous Power of Attorney granted by The Goldman Sachs Group, Inc. was superseded. |
| 2024-10-01 | Previous Power of Attorney granted by Goldman Sachs & Co. LLC was superseded. |
| 2025-07-16 | Date of execution for the current Power of Attorney by Goldman Sachs & Co. LLC, signed by Carey Ziegler. |
| 2025-12-31 | Date of event which required the filing of this Schedule 13G statement, reflecting the beneficial ownership. |
| 2026-01-06 | Date the Schedule 13G statement was signed and filed by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC. |
| 2026-07-16 | Expiration date of the current Power of Attorney, unless earlier revoked. |
Recommendation
holdThe filing indicates a significant passive stake by Goldman Sachs, which is generally a positive signal of institutional interest. However, as a Schedule 13G, it does not provide new financial or operational data about TNL MEDIAGENE to warrant a 'buy' recommendation. It primarily confirms a notable institutional presence, suggesting a 'hold' as investors await further company-specific news or financial results to assess the impact of this ownership.
Keywords
TNL MEDIAGENE, Goldman Sachs, Schedule 13G, Beneficial Ownership, Ordinary Shares, Institutional Investment, SEC Filing, G8924F121
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.